Holen Sie sich die Stockscreener-App
0.8452
1.86%
-0.016
Finanzdaten der Metagenomi Therapeutics Inc-Aktie (MGX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
10.38%
28.52
|
25.84 | 28.28 | 31.50 | 29.50 |
| Operating Income/Loss |
17.03%
-28.77
|
-24.59 | -24.37 | -22.84 | -20.99 |
| Nonoperating Income/Loss |
16.06%
1.291
|
1.538 | 1.873 | 2.212 | 1.123 |
| Income/Loss From Continuing Operations Before Tax |
19.23%
-27.48
|
-23.05 | -22.49 | -20.63 | -19.86 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.01 | 0.034 | -0.234 | 0.044 |
Net Income/Loss
|
19.18%
-27.48
|
-23.06 | -22.53 | -20.39 | -19.91 |
| Basic Average Shares |
0.21%
37.66
|
37.58 | 0.0747 | 37.35 | 37.16 |
| Diluted Average Shares |
0.21%
37.66
|
37.58 | 0.0747 | 37.35 | 37.16 |
| Basic Earnings Per Share |
19.67%
-0.73
|
-0.61 | -0.60 | -0.55 | -0.54 |
| Diluted Earnings Per Share |
19.67%
-0.73
|
-0.61 | -0.60 | -0.55 | -0.54 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):